| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Far Eastern Memorial Hospital |
| Information provided by: | Far Eastern Memorial Hospital |
| ClinicalTrials.gov Identifier: | NCT00318604 |
Purpose
This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.
| Condition |
|
Head and Neck Cancer Esophageal Cancer |
| MedlinePlus related topics: | Cancer Esophageal Cancer Esophagus Disorders Head and Neck Cancer |
| Study Type: | Observational |
| Study Design: | Longitudinal, Convenience Sample, Prospective Study |
Eligibility
| Ages Eligible for Study: | 18 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations More Information
| Study ID Numbers: | 94042 |
| First Received: | April 25, 2006 |
| Last Updated: | May 11, 2006 |
| ClinicalTrials.gov Identifier: | NCT00318604 |
| Health Authority: | Taiwan: Department of Health |
|
|
|
|
|
